What's Hot

    XRP Price Prediction: Can Ripple Extend Its Biggest Rally Since 2020? | Invesloan.com

    August 20, 2026

    Shein targets IPO for Sept. 1 — Reuters (SHEIN:Private) | Invesloan.com

    August 20, 2026

    Jared Moskowitz rejects Rick Scott’s declare he’d observe Hasan Piker | Invesloan.com

    August 20, 2026
    Facebook Twitter Instagram
    Finance Pro
    Facebook Twitter Instagram
    invesloan.cominvesloan.com
    Subscribe for Alerts
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    invesloan.cominvesloan.com
    Home » FDA drug analysis chief claims she was fired in company management shakeup | Invesloan.com
    Politics

    FDA drug analysis chief claims she was fired in company management shakeup | Invesloan.com

    May 16, 2026Updated:May 16, 2026
    Share
    Facebook Twitter LinkedIn Pinterest Email

    NEWYou can now listen to Fox News articles!

    Dr. Tracy Beth Høeg, former acting director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), became the second high-ranking official to depart the FDA this week after claiming she was fired Friday.

    Høeg’s departure came after that of former FDA Commissioner Dr. Marty Makary, who publicly resigned Tuesday after rumors that President Donald Trump was unhappy with him swirled for days.

    Høeg, who worked closely with Makary on regulating drugs before being elevated to CDER head in December, claimed she was forced out.

    TRUMP’S FDA BOSS RESIGNING AS ADMIN TAPS NEXT ACTING LEADER

    Food and Drug Administration Commissioner Marty Makary speaking at a press conference with Secretary Robert F. Kennedy Jr. in Washington, D.C.

    FDA Commissioner Marty Makary speaks during a press conference with HHS Secretary Robert F. Kennedy Jr. at the Department of Health and Human Services in Washington, D.C., on Oct. 29, 2025, discussing drug costs. (Annabelle Gordon/REUTERS)

    “I said I didn’t want to resign,” Høeg told MD Reports in an interview published Friday. “I said I’m not signing a letter of resignation if it’s not my choice.”

    Dr. Tracy Beth Hoeg sits in front of a card bearing her name.

    Dr. Tracy Beth Hoeg, former Acting Head of the FDA Center for for Drug Evaluation and Research (CDER), during a meeting of the CDC’s Advisory Committee On Immunization Practices at the Center for Disease Control (CDC) headquarters in Atlanta, Georgia, on Thursday, Dec. 4, 2025. (Megan Varner/Bloomberg via Getty Images)

    “They made it clear that it wasn’t their decision,” she told the outlet. “They said it was from someone above them, from someone way above their pay grade.”

    TRUMP FDA OVERHAULS COVID-19 VACCINE APPROVAL TO FOCUS ON OLDER POPULATIONS, HIGH-RISK INDIVIDUALS

    Høeg will be replaced by her former deputy, Dr. Mike Davis, according to an FDA email to staff obtained by The Associated Press.

    While the White House has yet to officially comment on her departure, Høeg’s exodus may be part of a larger shakeup following Makary’s resignation.

    In addition to Høeg, former director of the FDA’s Center for Biologics Evaluation and Research (CBER) Katherine Szarama is also leaving, along with FDA Chief of Staff Jim Traficant, according to reporting from STAT News.

    FDA Commissioner Dr. Marty Makary speaking at a podium

    FDA Commissioner Dr. Marty Makary resigned this week. (Andrew Harnik/Getty Images)

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    Fox News Digital contacted the White House, the FDA, HHS and Høeg for comment.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Keep Reading

    Jared Moskowitz rejects Rick Scott’s declare he’d observe Hasan Piker | Invesloan.com

    Rubio designates US scholar Min Zin wrongfully detained in China | Invesloan.com

    Israel Katz warns Erdogan in opposition to testing Israel’s resolve in Syria | Invesloan.com

    Tulsi Gabbard offers promising information on husband’s bone most cancers surgical procedure | Invesloan.com

    Raiders vs Texans and 49ers vs Chargers spotlight NFL preseason slate with key quarterback matchups | Invesloan.com

    Austin Abrams fights to flee a 60-ton sperm whale in new ‘Whalefall’ trailer with Josh Brolin | Invesloan.com

    Smokin’ Charley Hull respects summer season in a scorching new social media put up, Little League drama & unlawful deal with | Invesloan.com

    California reparations invoice targets company chattel slavery ties | Invesloan.com

    5 easy way of life modifications that might assist shield in opposition to most cancers | Invesloan.com

    LATEST NEWS

    XRP Price Prediction: Can Ripple Extend Its Biggest Rally Since 2020? | Invesloan.com

    August 20, 2026

    Shein targets IPO for Sept. 1 — Reuters (SHEIN:Private) | Invesloan.com

    August 20, 2026

    Jared Moskowitz rejects Rick Scott’s declare he’d observe Hasan Piker | Invesloan.com

    August 20, 2026

    The Real Ages of ‘Outer Banks’ Cast Vs. Their Characters | Invesloan.com

    August 20, 2026
    POPULAR

    China’s first passenger jet completes maiden commercial flight

    May 28, 2023

    Numbers taking US accountancy exams drop to lowest level in 17 years

    May 29, 2023

    Toyota chair faces removal vote over governance issues

    May 29, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!
    Facebook Twitter Pinterest WhatsApp Instagram
    © 2007-2023 Invesloan.com All Rights Reserved.
    • Privacy
    • Terms
    • Press Release
    • Advertise
    • Contact

    Type above and press Enter to search. Press Esc to cancel.

    invesloan.com
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}